OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
July 16, 2019
An agreement with Sanofi gives Catalent access to commercial spray drying facility in Haverhill, UK.
July 02, 2019
Several trends are driving change in oral solid‑dosage forms and giving rise to the requirement of ‘fit-for-purpose’ excipients.
July 01, 2019
More than 30 lots of losartan drug products have been recalled due to contaminated API manufactured by Hetero Labs.
Novavax will sell two Maryland-based vaccine development and manufacturing facilities for Catalent’s expanding gene therapy footprint.
June 17, 2019
Two additional production lines expand Lonza’s HPAPI capacity at Visp, Switzerland facility.
June 07, 2019
Tergus Pharma announced a partnership with Great Point Partners and construction of a new commercial manufacturing facility in North Carolina.
June 06, 2019
European midmarket private equity group, Duke Street, has agreed to acquire Kent Pharmaceuticals and Athlone Laboratories from DCC Vital.
June 02, 2019
A simple, one-part DPI aims to make inhalation drug treatment more accessible and affordable.
Excipients and new processing techniques can make a real difference in the development of highly potent therapies.
Wearable and smart devices allow user-friendly subcutaneous drug delivery.